Engineering Multi-Functional Nanomaterials to Treat Metastatic Cancer.

Al-Jamal, Wafa (Principal Investigator)

School of Pharmacy

Status	Finished
Effective start/end date	18/05/15 → 21/07/17

Funding

Engineering and Physical Sciences Research Council: £99,870.00

4 Article

Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy
Silva, V. & Al-Jamal, W. T., 10 May 2017, In : Journal of Controlled Release. 253, p. 82–96
Research output: Contribution to journal › Article

Open Access
File

44 Citations (Scopus)

4 Downloads (Pure)
Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A)
Borrello, M. T., Schinor, B., Bartels, K., Benelkebir, H., Pereira, S., Al-Jamal, W. T., Douglas, L., Duriez, P. J., Packham, G., Haufe, G. & Ganesan, A., 15 May 2017, In : Bioorganic & Medicinal Chemistry Letters. 27, 10, p. 2099–2101
Research output: Contribution to journal › Article

Open Access
File

12 Citations (Scopus)

16 Downloads (Pure)
Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy
Hodgins, N. O., Al-Jamal, W. T., Wang, J. T-W., Klippstein, R., Sosabowski, J. K., Marshall, J. F., Maher, J. & Al-Jamal, K. T., 28 Jun 2017, In : Journal of Controlled Release. 256, p. 141-152 12 p.
Research output: Contribution to journal › Article

Open Access
File

16 Citations (Scopus)

3 Downloads (Pure)